Wenning M, Höpker W W
Virchows Arch A Pathol Anat Histol. 1981;391(2):207-15. doi: 10.1007/BF00437597.
In an experimental comparative study on rabbits, the efficacy of the reduction of surface thrombus formation was investigated using heparinized central venous catheters compared with non-heparinized. Up to a central indwelling period of ten days, there was a reduction of the thrombus layer thickness on the heparinized catheters of 80% (with a trial duration of three days this was as much as 90%). The action of the stabilized surface heparin, which leads to a substantial thromboresistance, is complex in nature. 1) By intensified adsorption of plasma proteins in the early phase (proteins consist of antithrombin III, factor IX, X and XI), there is very much less thrombocyte adhesion and aggregation on the heparinized catheter surfaces. 2) The externally orientated negative net charge of the heparin shows a similar effect. 3) If there is thrombocyte adhesion despite this, further heparin effects become more prominent. Thus the release of ThF 3 and ADP, which leads to aggregation, is markedly inhibited. On the other hand, this leads to easier dissolution of already aggregated thrombocytes and on the other to a reduction of the catalytic thrombocyte surface for the plasma clotting factors. 4) This effect is supported by the increased adsorption of antithrombin III onto the control surface. 5) Finally there is also an inhibitory effect of heparin on the activated Stuart-Prower factor. Local thrombosis on the venous catheter surface can thus be effectively reduced by local therapy, without greater risks for the intensive care patient.
在一项针对兔子的实验性比较研究中,研究了肝素化中心静脉导管与非肝素化中心静脉导管相比在减少表面血栓形成方面的效果。在长达十天的中心留置期内,肝素化导管上的血栓层厚度减少了80%(在为期三天的试验中,这一比例高达90%)。稳定化表面肝素导致显著抗血栓形成的作用本质上很复杂。1)在早期通过强化血浆蛋白吸附(这些蛋白包括抗凝血酶III、因子IX、X和XI),肝素化导管表面的血小板黏附和聚集大大减少。2)肝素向外的负净电荷显示出类似效果。3)尽管如此,如果仍有血小板黏附,进一步的肝素作用会更加显著。因此,导致聚集的ThF 3和ADP的释放受到明显抑制。另一方面,这使得已经聚集的血小板更容易溶解,并且另一方面减少了血浆凝血因子的催化血小板表面。4)抗凝血酶III在对照表面上吸附增加支持了这一效果。5)最后,肝素对活化的斯图尔特-普劳厄因子也有抑制作用。因此,通过局部治疗可有效减少静脉导管表面的局部血栓形成,而不会给重症监护患者带来更大风险。